Salk Institute for Biological Studies
Molecular Neurobiology Laboratory
Greg Lemke is Françoise Gilot-Salk Professor at the Salk Institute for Biological Studies, where he is a member of the Molecular Neurobiology Laboratory and the Immunobiology and Microbial Pathogenesis Laboratory. He is also Adjunct Professor of Neurosciences, and Biomedical Sciences, at the University of California San Diego. Dr. Lemke received an SB in biology from MIT in 1978, and a PhD in biology from Caltech in 1983. Following postdoctoral study with Richard Axel at Columbia University, he joined the Salk Institute faculty in 1985. His lab has made major contributions to our understanding of the role that receptor tyrosine kinases (RTKs) play in mammalian development and physiology. A major focus of his current research is the TAM family of RTKs – Tyro3, Axl, and Mer – and how this family functions in immune regulation, virus infection, neurodegenerative disease, and cancer.

Moderator of 1 Session

Session Type
SYMPOSIUM
Date
Wed, 16.03.2022
Session Time
04:15 PM - 06:00 PM
Room
ONSITE: 113

Presenter of 1 Presentation

MICROGLIAL TAM RECEPTORS IN ALZHEIMER’S DISEASE

Session Type
PLENARY LECTURE
Date
Sat, 19.03.2022
Session Time
08:30 AM - 09:00 AM
Room
ONSITE PLENARY: 115-117
Lecture Time
08:30 AM - 09:00 AM

Abstract

Abstract Body

Two microglial TAM receptor tyrosine kinases - Axl and Mer - have been linked to Alzheimer’s disease, but their roles in disease have not been tested experimentally. We find that in Alzheimer’s disease and its mouse models, induced expression of Axl and Mer in amyloid plaque-associated microglia is coupled to induced plaque decoration by the TAM ligand Gas6 and its co-ligand phosphatidylserine. In the APP/PS1 mouse model of Alzheimer’s disease, we show that genetic ablation of Axl and Mer results in microglia that are unable to normally detect, respond to, organize, or phagocytose amyloid beta plaques. These major deficits notwithstanding, and contrary to expectation, TAM-deficient APP/PS1 mice develop fewer dense-core plaques than APP/PS1 mice with normal microglia. Our findings reveal that the TAM system is an essential mediator of microglial recognition and engulfment of amyloid plaques, and that TAM-driven microglial phagocytosis does not inhibit, but rather promotes, dense-core plaque development. Thus, dense-core plaques do not form spontaneously, but are instead constructed via microglial phagocytosis, and much of this phagocytosis is mediated by Mer and Axl. With regard to their construction by microglia, dense-core plaques may be viewed as macrophage-generated granulomas. As such, their simple dis-aggregation by drugs such as aducanumab may be contraindicated as an Alzheimer's disease therapy.

Hide